Kiwi Biosciences
Patent-pending enzymes to break down common dietary triggers
Boston, United States · Founded 2020 · $1.5M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Founded
- 2020
- Website
- fodzyme.com
- Total Funding
- $1.5M
- Last Round
- $1.5M SeedOct 2021
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Kiwi Biosciences can help 18M Americans suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without running to the bathroom two hours later. We develop novel, patent-pending enzymes that break down common digestive triggers in food.
Summary
Kiwi Biosciences is a Biotech company based in Boston, United States, founded in 2020. It has raised $1.5M in total across 1 round, most recently a $1.5M Seed round in Oct 2021. Investors include Y Combinator and North South Ventures.
Tech & App Stack
18 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2021
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kiwi-biosciences"><img src="https://indexed.vc/api/badge/company/kiwi-biosciences" alt="Kiwi Biosciences on Indexed.vc" width="260" height="76" /></a>